Endometriosis, Endometrial Polyps
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.?Patients diagnosed with endometriosis (EM) via laparoscopy or laparotomy.(test team); 2.?Postoperative pathological confirmation of ectopic endometrial tissue and diagnosis of endometrial polyps (EP) by hysteroscopy.(test team); 3.?No history of hormonal medication use for at least 3 months prior to sample collection.(test team); 4.?Signed informed consent form for the use of human biological tissue specimens in scientific research.(test team); 5.?Patients diagnosed with endometrial polyps ( EP ) by hysteroscopy.( control group ); 6.?Patients with endometrial polyps (EP) confirmed by hysteroscopy, who were excluded from endometriosis (EM) through imaging, laparoscopy, or laparotomy.( control group ); 7.?Postoperative pathological examination confirmed endometrial polyps. ( control group ); 8.?No history of hormonal medication use for at least 3 months prior to sample collection.( control group ); 9.?Signed informed consent form for the use of human biological tissue specimens in scientific research.( control group );
Exclusion criteria
Exclusion criteria: 1.Presence of other systemic diseases or severe comorbidities (e.g., diabetes, hypertension, cardiovascular diseases) potentially affecting study outcomes. 2.Recent (within the past 3 months) history of radiotherapy, chemotherapy, or other treatments significantly affecting the endometrium. 3.Failure to sign the Informed Consent Form for the Use of Human Biological Tissue Specimens in Scientific Research;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Related gene mRNA expression levels;Immunohistochemical staining rate of ECM1 pathological sections; | — |
Secondary
| Measure | Time frame |
|---|---|
| In vitro cell function experiments; | — |
Countries
China
Contacts
Shaoxing Maternity and Child Health Care Hospital